Lyra Therapeutics stock forecast
Want to see LYRA full AI Analyst Report?
Lyra Therapeutics (LYRA) Stock Forecast & Price Target
LYRA Analyst Ratings
LYRA Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Justin Zelin | BTIG | ― | hold | ― | Reiterated | 11/13/25 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Justin ZelinBTIG | HoldReiterated | 11/13/25 | ― |
Best Analysts Covering Lyra Therapeutics
Copying DeepSeek Biotechnology's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +15.00% per trade.
Copying DeepSeek Biotechnology's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +15.00% per trade.
Copying DeepSeek Biotechnology's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +15.00% per trade.
LYRA Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 1 | 0 | 0 | 0 |
In the current month, LYRA has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. LYRA average Analyst price target in the past 3 months is ―.
LYRA Financial Forecast
LYRA Sales Forecast
Next quarter’s sales forecast for LYRA is $0 with a range of ― to ―. The previous quarter’s sales results were $7,000. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
